专题：Hepatitis C virus research

This cluster of papers focuses on the epidemiology, treatment, and outcomes of hepatitis C virus infection. It covers topics such as antiviral therapy, genetic variation in viral clearance, global epidemiology, liver-related mortality, immune responses, and the impact of comorbidities like HIV and diabetes.
最新文献
A longitudinal cohort study uncovers plasma protein biomarkers predating clinical onset and treatment response of rheumatoid arthritis

article Full Text OpenAlex

High‐Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With HBsAg Seroclearance

article Full Text OpenAlex

Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States

article Full Text OpenAlex

Hepatitis C Screening in Emergency Departments

letter Full Text OpenAlex

Impact of Socio‐Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B

article Full Text OpenAlex

A Multifaceted Approach Leads to Improved Linkage to HCV Therapy: A Multicenter Randomised Controlled Trial

article Full Text OpenAlex

Hepatitis B Virus Variants and Cytokine Patterns in Acute Liver Failure and Transplant‐Free Survival

article Full Text OpenAlex

Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold

article Full Text OpenAlex

Metabolic Factors Drive Early Increase in Hepatic Steatosis Despite Improvement in Non-Invasive Fibrosis Markers after Hepatitis C Eradication with Direct-Acting Antivirals

article Full Text OpenAlex

Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV

review Full Text OpenAlex

近5年高被引文献
Hepatocellular carcinoma

review Full Text OpenAlex 4895 FWCI153.889

Advancing the global public health agenda for NAFLD: a consensus statement

review Full Text OpenAlex 583 FWCI21.299

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

review Full Text OpenAlex 500 FWCI30.021

Corrigendum to ‘EASL recommendations on treatment of hepatitis C: Final update of the series’ [J Hepatol 73 (2020) 1170–1218]

erratum Full Text OpenAlex 446 FWCI0

Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

article Full Text OpenAlex 441 FWCI78.519

Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach

review Full Text OpenAlex 409 FWCI14.909

Immunobiology and pathogenesis of hepatitis B virus infection

review Full Text OpenAlex 384 FWCI13.562

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

article Full Text OpenAlex 373 FWCI74.316

Hepatitis B

review Full Text OpenAlex 338 FWCI26.48

Global burden of hepatitis B virus: current status, missed opportunities and a call for action

review Full Text OpenAlex 333 FWCI26.162